✕
Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
 简体中文
(Simplified Chinese) 繁體中文
(Traditional Chinese)
BioSTL News Update – MediBeacon Announced as Winner St. Louis Regional Business Plan Competition

MediBeacon, a new St. Louis-based optical diagnostic company, has won the 2012 St. Louis Regional Business Plan Competition, beating out some of the most innovative small businesses in St. Louis. With the recognition, MediBeacon receives a $50,000 grant award and 90 hours of in-kind professional services to advance the first product from their portfolio – a groundbreaking platform that allows medical staff to monitor patient kidney function safely, more accurately, and in real time by utilizing a breakthrough fluorescent tracer agent combined with an optical sensor placed on a patient’s forehead or finger.

BioSTL’s affiliate, the BioGenerator, provided business assistance and funding to MediBeacon through the U.S. Department of Commerce funded i6 Challenge program that supports the launch of local bioscience startups. MediBeacon also utilizes the shared laboratory facilities of the BioGenerator Accelerator Labs. This marks the third year in a row that a BioGenerator portfolio company has won the award, following Pulse Therapeutics in 2011 and Mobius Therapeutics in 2010.

Additional winners in this year’s business plan competition include iLer Brands and Retectix, a bioscience company whose nanofabricated surgical mesh reduces the risk of patient complications from surgery. They will receive $30,000 and $20,000 grant awards, respectively.

MediBeacon Leadership: From L to R: Terence Stern, Vice President Business Development; Richard Dorshow, President, Chief Scientific Officer; Steven Hanley, Chief Executive Officer

# # #

CONTACT:
Steve Hanley
MediBeacon LLC
Office - 314-269-5808
Email - hanley@medibeacon.com
www.medibeacon.com

1100 Corporate Square Drive
Helix Center, Suite 229
St Louis MO 63132

United States
MediBeacon Inc.
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 269-5808

Germany
MediBeacon GmbH
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15

Greater China
(Exclusive Commercial Partner)
Huadong Medicine Co., Ltd
Telephone: 4008-269-985
+86-(0)571-89908581
Zip: 310011
Address: No.866. Moganshan Road, Hangzhou, Zhejiang Province, China
Email: info@eastchinapharm.com

Science How it Works R&D Platform Product Pipeline Patent Estate Preclinical Clinical Focus Areas Nephrology Gastroenterology Ophthalmology Surgery In Discovery
Publications MediBeacon Publications Preclinical Publications Industry Literature Company History People By the Numbers Quality Commitment News/Media Contact Get Updates Investors General Questions

*MediBeacon products are in various stages of clinical development and are not yet approved for human use.

**The Transdermal GFR Measurement System (TGFR) is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function. References on this website to measured kidney function and measured renal function refer to the measured GFR.

Terms and Conditions | Privacy Policy | © 2021 MediBeacon All Rights Reserved.

COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.